Document is current
Any future updates will be listed below
-
Authors
Wall, Matthew A.
Turkarslan, Serdar
Wu, Wei-Ju
Danziger, Samuel A.
Reiss, David J.
Mason, Mike J.
Dervan, Andrew P. https://orcid.org/0000-0002-6482-8654
Trotter, Matthew W. B.
Bassett, Douglas
Hershberg, Robert M.
Lomana, Adrián López García de
Ratushny, Alexander V. https://orcid.org/0000-0002-1701-4084
Baliga, Nitin S. https://orcid.org/0000-0001-9157-5974
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIH NIAID R01 AI141953)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIH NIAID R01 AI141953)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIH NIAID R01 AI141953)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIH NIAID R01 AI141953)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIH NIAID R01 AI141953)
Additional funding from Institute for Systems Biology and Celgene/BMS
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
National Science Foundation (NSF ABI 1565166)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 1 August 2020
Accepted: 13 May 2021
First Online: 28 June 2021
Competing interests
: S.A.D., D.J.R., A.P.D., M.W.B.T., D.B., and A.V.R. declare employment and equity ownership for Bristol-Myers Squibb Corporation. R.M.H. declares former employment and equity ownership for Celgene Corporation; membership on an entity’s Board of Directors or advisory committee for Adaptive Biotechnologies and NanoString Technologies; consultancy at Fraizer Healthcare Partners.
